| |
Notice of the making of this Statutory Instrument was published in
|
| |
“Iris Oifigiúil” of 31st December, 2019.
|
| |
I, SIMON HARRIS, Minister for Health, in exercise of the powers conferred on me by sections 4 and 5 (as amended by
section 15
of the
Misuse of Drugs Act 1984
(No. 18 of 1984) and
section 3
of the
Misuse of Drugs (Amendment) Act 2016
(No. 9 of 2016)) of the
Misuse of Drugs Act 1977
(No. 12 of 1977), hereby make the following regulations:
|
| |
1. These Regulations may be cited as the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019.
|
| |
2. The Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 (S.I. No. 262 of 2019) are amended by substituting for Schedule 1 the following:
|
| |
“SCHEDULE 1
|
| |
Regulation 2
|
| |
Specified Controlled Drugs
|
| |
Name of Cannabis product or preparation and brand name
|
Dosage form
|
Concentration of THC (percentage, weight/weight or weight/volume)
|
Name of manufacturer
|
Aurora High CBD Oil Drops
|
Oral solution
|
Less than 3% w/v (< 30mg/ml)
This product also contains cannabidiol (CBD) 60% w/v (600mg/ml)
|
Aurora Cannabis Enterprises Inc., 4439 Township Road 304,Cremona, Alberta,Canada, T0M 0R0
|
CannEpil ™
|
Oral solution
|
0.5% w/v (5mg/ml)
This product also contains cannabidiol (CBD) 10% w/v (100mg/ml)
|
MGC Pharmaceuticals d.o.o.,
Kamniška ulica 29, 1000, Ljubljana, Slovenia
|
Tilray Oral Solution THC10:CBD10 25ml
|
Oral solution
|
1% w/v (10mg/ml)
This product also contains cannabidiol (CBD) 1% w/v (10mg/ml)
|
Tilray Canada Ltd., 1100 Maughan Road, Nanaimo, BC, V9X 1J2, Canada
|
|
| |
”.
|
| |
![http://www.irishstatutebook.ie/images/ls](http://www.irishstatutebook.ie/images/ls)
|
| |
GIVEN under my Official Seal,
|
| |
17 December, 2019.
|
| |
SIMON HARRIS,
|
| |
Minister for Health.
|
| |
EXPLANATORY NOTE
|
| |
(This note is not part of the Instrument and does not purport to be a legal interpretation.)
|
| |
The purpose of these Regulations is to amend the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 to replace Schedule 1 in order to list certain cannabis products or preparations for medical use as “specified controlled drugs”.
|
| |
These Regulations may be cited as the Misuse Of Drugs (Prescription And Control Of Supply Of Cannabis For Medical Use) (Amendment) Regulations 2019.
|